USPTO serial 88400241
VERITY
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Aug 4, 2026
- Examiner
- JENKINS JR, CHARLES L
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with VERITY?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Lynne E. Graybeal
Lynne E. Graybeal PERKINS COIE LLPP.O. Box 2608SEATTLE, WA 98111United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 035 | Advisory and consulting services in the field of cost management of health care and pharmaceuticals; Business advisory and consulting services in the field of health care and pharmaceutical benefit programs; pharmaceutical cost management advisory and consulting services regarding the administration of the federal 340B prescription drug discount program and maximization of benefits; providing an online computer database for collecting and reporting pharmacy management and drug dispensing information for business purposes; data management services, namely, electronic data collection, online claims management, and financial reconciliation of accounts on behalf of others; administration coordination services in the nature of facilitating administrative coordination between health care facilities, pharmacies, and insurance plans; inventory management; Business consulting services in the fields of the business management and administration of Federal 340B pharmacy programs and discount prescription drug programs; business management and administration of Federal 340B pharmaceutical programs and discount prescription drug programs; Business and Inventory management services provided to eligible organizations in the healthcare fields for controlling drug inventories; business and inventory management services provided to eligible pharmacies for controlling drug inventories; business assistance, advisory services, and consultancy in the field of assisting others in preparing and filing applications for eligible health care facilities and pharmacies in the fields of Federal 340B pharmaceutical programs and discount prescription drug programs with governmental regulatory bodies for business purposes; business consulting services, relating to operations management services, managing the flow of inventory, business information, and accounts receivable billing between health centers, pharmacies, wholesalers, and insurance companies; business assistance, advisory services, and consultancy, namely, assisting others in preparing and filing applications for eligible health care facilities and pharmacies in the fields of Federal 340B pharmaceutical programs and discount prescription drug programs with governmental regulatory bodies for business purposes; audit support services, namely, audit policy and procedures guidance, review of audit documents, data and procedures, preparation, organization, and presentation of the documents and data requested by a government body or third party, and providing business advice on government or third party audit processes, policies, and strategies; specialty retail pharmacy services; interactive record-keeping services for use in regulatory compliance by professionals in the healthcare, medical and pharmaceutical fields; consulting services in the field of pharmaceutical cost management services and drug utilization review services; business consulting services in the fields of pharmacy and prescription medication benefits; business consulting services in the field of healthcare benefits | ACTIVE | — |
| 036 | Advisory and consulting services in the field of pharmaceutical benefit management services; pharmacy benefit management services; pharmacy benefit and claims processing management services; financial consulting services in the fields of healthcare benefits; financial consulting services in the fields of pharmacy and prescription medication benefits; consulting services in the field of pharmaceutical benefit management services; consulting services in the field of pharmaceutical benefit management services of Federal 340B pharmacy programs, and discount prescription drug programs | ACTIVE | — |
| 042 | Software as a Service (SAAS) services featuring software for use with managing medical and pharmaceutical records and data; computer services, namely, providing search engine services for obtaining and managing medical and pharmaceuticals records and data on a global computer network; Software as a Service (SAAS) services featuring software for cost management in the field of health care and pharmaceuticals; software as a service (SAAS) services featuring software for use with self-auditing company records to ensure compliance with, and maximizing the benefits of, health care and pharmaceutical benefit programs; software as a service (SAAS) services featuring software for administering and maximizing the use of the federal 340B prescription drug discount program through organization of information and implementation of automated duty allocation, automated risk scoring, and expert-defined tasks and assessment steps | ACTIVE | — |
| 044 | Advisory and consulting services in the field of health care; Medical and pharmaceutical consultation | ACTIVE | — |
| 045 | Regulatory compliance consulting in the fields of healthcare, pharmaceutical, Federal 340B pharmacy programs, and discount prescription drug programs; regulatory compliance consulting services in the fields of healthcare, pharmaceuticals and Federal 340B pharmaceutical program in the nature of compliance, auditing, and reviewing contracts, systems, procedures, and policies, all for compliance with government regulations; reviewing standards and practices to assure compliance with laws and regulations relating to healthcare and pharmaceutical benefit plans; regulatory compliance consulting in the field of assisting others in preparing and filing applications for eligible health care facilities and pharmacies in the fields of Federal 340B pharmaceutical programs and discount prescription drug programs with governmental regulatory bodies; advisory and consulting services in the field of health care and pharmaceutical regulatory compliance | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Verity Solutions Group, Inc.
- Other trademarks owned by Verity Solutions Group, Inc.
- Other trademarks owned by Verity Solutions Group, Inc.
- Other trademarks in Class 035
- Other trademarks in Class 036
- Other trademarks in Class 042
- Other trademarks in Class 044
- Other trademarks in Class 045
- Similar marks named VERITY
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 4, 2026 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Aug 4, 2026 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jul 13, 2026 | SUNA | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | — |
| Jul 13, 2026 | CNPR | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | — |
| Jun 10, 2026 | SUPC | STATEMENT OF USE PROCESSING COMPLETE | — |
| Feb 24, 2026 | IUAF | USE AMENDMENT FILED | — |
| Feb 24, 2026 | EISU | TEAS STATEMENT OF USE RECEIVED | The applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action. |
| Feb 21, 2026 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Feb 20, 2026 | EX4G | SOU EXTENSION 4 GRANTED | — |
| Feb 20, 2026 | EXT4 | SOU EXTENSION 4 FILED | — |
| Feb 20, 2026 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Oct 7, 2025 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Oct 6, 2025 | EX3G | SOU EXTENSION 3 GRANTED | — |
| Oct 6, 2025 | EXT3 | SOU EXTENSION 3 FILED | — |
| Oct 6, 2025 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Mar 12, 2025 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Mar 11, 2025 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Mar 11, 2025 | EXT2 | SOU EXTENSION 2 FILED | — |
| Mar 11, 2025 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Oct 8, 2024 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Oct 8, 2024 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Oct 8, 2024 | EXT1 | SOU EXTENSION 1 FILED | — |
| Oct 8, 2024 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Apr 9, 2024 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Feb 13, 2024 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Feb 13, 2024 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jan 24, 2024 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jan 5, 2024 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jan 5, 2024 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jan 5, 2024 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Nov 22, 2023 | ERSI | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | — |
| May 26, 2023 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| May 26, 2023 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| May 26, 2023 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Apr 18, 2023 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Apr 18, 2023 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Apr 18, 2023 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Mar 17, 2023 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Mar 16, 2023 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 16, 2023 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Dec 20, 2022 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 20, 2022 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 20, 2022 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 8, 2022 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Nov 8, 2022 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Nov 8, 2022 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Oct 4, 2022 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Oct 4, 2022 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Oct 4, 2022 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 10, 2022 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 10, 2022 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 10, 2022 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 9, 2022 | RCSC | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | — |
| Aug 13, 2021 | RCSC | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | — |
| Jan 21, 2021 | RCSC | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | — |
| Jun 29, 2020 | RCSC | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | — |
| Dec 6, 2019 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Dec 6, 2019 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Dec 6, 2019 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Nov 14, 2019 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Nov 14, 2019 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Nov 14, 2019 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jun 13, 2019 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 13, 2019 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 13, 2019 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 5, 2019 | DOCK | ASSIGNED TO EXAMINER | — |
| May 9, 2019 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Apr 27, 2019 | NWAP | NEW APPLICATION ENTERED | — |